文献速递甲状腺疾病

甲状腺未分化癌转录组揭示两种具有不同肿瘤微环境和预后的分子亚型

Transcriptome of Anaplastic Thyroid Cancer Reveals Two Molecular Subtypes with Distinct Tumor Microenvironment and Prognosis.
PubMed 文献 · Thyroid · 2025-01-27

该研究分析1634份甲状腺样本的转录组数据,包括74例甲状腺未分化癌(ATC),用去卷积分析评估肿瘤微环境(TME)。ATC的TME以免疫细胞和成纤维细胞丰度高、上皮细胞丰度低为特征,可进一步分为ATC-IF和ATC-E两种分子亚型,其中ATC-IF组疾病特异性生存更差(log-rank p=0.035),ERK评分更高、甲状腺分化评分更低。

要点

  • ATC的TME以免疫细胞和成纤维细胞丰度高、上皮细胞丰度低为特征,不同于分化型甲状腺癌。
  • ATC可分成ATC-IF和ATC-E两个分子亚型,ATC-IF组疾病特异性生存更差(log-rank p=0.035)。
  • ATC-IF组ERK评分更高、甲状腺分化评分更低,免疫检查点基因表达和上皮-间质转化评分显著高于ATC-E组。

核心结论

  • ATC的TME不同于分化型甲状腺癌,可进一步分为两种具有各自独特TME的分子亚型;ATC-IF组预后更差、ERK评分更高,富含免疫细胞和成纤维细胞,可能代表潜在治疗靶点。

研究设计与样本

  • 研究分析1634份样本的bulk RNA转录组数据,包括476份正常甲状腺组织、25例良性甲状腺腺瘤、340例RAS样和719例BRAFV600E样分化型甲状腺癌(分别为DTC-R和DTC-B)以及74例ATC。
  • 采用去卷积分析评估上述甲状腺癌亚型的TME和分子特征。

主要发现

  • 与其他甲状腺组织学类型相比,ATC的TME以免疫细胞和成纤维细胞丰度高、上皮细胞丰度低为特征。
  • 在恶性演化过程中,ATC表现出的生态型与DTC-B的关系比与RAS样DTC(DTC-R)更密切。
  • 在ATC中识别出两种TME存在显著差异的分子亚型:免疫细胞和成纤维细胞增多的亚型称为ATC-免疫-成纤维细胞(ATC-IF),上皮和内皮细胞升高的亚型称为ATC-上皮-内皮(ATC-E)。
  • ATC-IF组疾病特异性生存差于ATC-E组(log-rank p=0.035),且ERK评分更高、甲状腺分化评分更低。
  • 与DTC-R和DTC-B相比,两种ATC亚型的免疫细胞和成纤维细胞均增多,但ATC-IF组增加更明显,髓系细胞和促迁移成纤维细胞显著上升;ATC-IF组免疫检查点基因表达和上皮-间质转化评分显著高于ATC-E组。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Although patients with anaplastic thyroid cancer (ATC) generally have a poor prognosis and there are currently no effective treatment options, survival and response to therapy vary between patients. Genomic and transcriptomic profiles of ATC have been reported; however, a comprehensive study of the tumor microenvironment (TME) of ATC is still lacking. This study aimed to elucidate the TME characteristics associated with ATC and their prognostic implications. Methods: We analyzed bulk RNA transcriptomic data from 1,634 samples-including 476 normal thyroid tissues, 25 benign thyroid adenomas, 340 RAS-like and 719 BRAFV600E-like differentiated thyroid cancers (DTC-R and DTC-B, respectively), and 74 ATCs. We assessed the TME and molecular characteristics of these thyroid cancer subtypes using deconvolution analysis. Results: The TME of ATC was characterized by a high abundance of immune cells and fibroblasts and a low abundance of epithelial cells compared to other thyroid histologies. During its malignant evolution, ATC exhibited an ecotype more closely related to DTC-B than RAS-like DTC (DTC-R). Furthermore, we identified two distinct molecular subtypes within ATC with significant differences in their TMEs. We termed the subtype with increased immune cells and fibroblasts as ATC-immune-fibroblast (ATC-IF) and the subtype with elevated epithelial and endothelial cells as ATC-epithelial-endothelial (ATC-E). The ATC-IF group had worse disease-specific survival (log-rank p = 0.035), higher ERK scores, and lower thyroid differentiation scores than the ATC-E group. While both ATC subtypes had elevated immune cells and fibroblasts compared to DTC-R and DTC-B, this increase was more pronounced in ATC-IF, with a marked rise in myeloid lineage cells and promigratory fibroblasts. Immune checkpoint gene expression and epithelial-mesenchymal transition scores were significantly higher in the ATC-IF group than in the ATC-E group. Conclusion: ATC shows a TME distinct from that of DTC and can be further divided into two molecular subtypes-each with its own unique TME. The ATC-IF group, with a poorer prognosis and higher ERK score, is enriched in immune cells and fibroblasts, which may represent potential therapeutic targets.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Byun H, Lee HS, Song YS, et al. Transcriptome of Anaplastic Thyroid Cancer Reveals Two Molecular Subtypes with Distinct Tumor Microenvironment and Prognosis. Thyroid. 2025. PMID: 39869083. doi:10.1089/thy.2024.0266

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。